Effect of Sporlac on Blood Sugar Levels
Phase 3
Completed
- Conditions
- Health Condition 1: null- Diabetes
- Registration Number
- CTRI/2017/12/010802
- Lead Sponsor
- Sanzyme Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 4
Inclusion Criteria
1.Healthy adult males between 40 and 60 years of age
2.Subjects providing written informed consent
Exclusion Criteria
1.Subjects with impaired glucose tolerance
2.Subjects with known allergy to Sporlac or its constituents
3.Subjects with any disorder that might affect their GI function
4.Patients with active liver or kidney disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of pre-treatment with Sporlac on fasting blood sugar and glycaemic response to foodTimepoint: 9 Days
- Secondary Outcome Measures
Name Time Method To assess the safety of Sporlac in healthy individualsTimepoint: 9 Days